A Multicenter, Open-label, Single Dose Study of the Safety and Efficacy of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Focal Upper Limb Spasticity

Details: By ClinicalTrials.gov; Category: Muscle Diseases; Sep 3, 2010

Condition: Spasticity, Post-Stroke
Intervention: Drug: Botulinum toxin type A
Sponsor: GlaxoSmithKline
Recruiting - verified August 2011

Last Updated: 03 September 2010

Muscle Diseases Clinical Trials

A Multicenter, Open-label, Single Dose Study of the Safety and Efficacy of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Focal Upper Limb Spasticity

Home

News

Specialists

Muscle Diseases Clinical Trials

A Multicenter, Open-label, Single Dose Study of the Safety and Efficacy of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Focal Upper Limb Spasticity

TPL_FOLLOW_US

Home

News

Specialists